Home › Funds › SIGNAL TREE FINANCIAL PARTNERS LLC › ABT

SIGNAL TREE FINANCIAL PARTNERS LLC position in ABT

ABBOTT LABORATORIES · Health Care

SIGNAL TREE FINANCIAL PARTNERS LLC reported holding 2,611 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$258K, representing 0.17% of its reported portfolio and ranking #46 among its reported holdings. SIGNAL TREE FINANCIAL PARTNERS LLC has disclosed ABT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)2.61K sh
Reported value held$258.01K
Portfolio Weight0.17%
First reportedQ4 2024
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How SIGNAL TREE FINANCIAL PARTNERS LLC's ABT position evolved

SIGNAL TREE FINANCIAL PARTNERS LLC first disclosed a stake in ABT in Q4 2024 at 2,715 shares (US$307K). The position peaked in Q2 2025 at 2,604 shares, worth US$354K. Across 8 filings, SIGNAL TREE FINANCIAL PARTNERS LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 2,611 shares valued at US$258K.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 2.71K $307.05K New
Q1 2025 2.60K $345.37K Reduce
Q2 2025 2.60K $354.12K Hold
Q3 2025 2.60K $347.50K Hold
Q4 2025 2.60K $326.21K Hold
Q1 2026 2.59K $265.98K Hold
Q2 2026 2.60K $236.16K Hold
Q3 2026 2.61K $258.01K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.65B), Charles Schwab Investment Management (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has SIGNAL TREE FINANCIAL PARTNERS LLC held ABT?

SIGNAL TREE FINANCIAL PARTNERS LLC has disclosed ABT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is SIGNAL TREE FINANCIAL PARTNERS LLC's current position in ABT?

As of Q3 2026, SIGNAL TREE FINANCIAL PARTNERS LLC holds 2.61K shares of ABT (ABBOTT LABORATORIES), valued at $258.01K, representing 0.17% of its reported portfolio and ranking #46.

Has SIGNAL TREE FINANCIAL PARTNERS LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), SIGNAL TREE FINANCIAL PARTNERS LLC held unchanged its position in ABT. The position peaked in Q2 2025 at 2.60K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.